Login/Sign Up
₹211176.2*
MRP ₹257532
18% off
₹218902.2*
MRP ₹257532
15% CB
₹38629.8 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Country of origin
Alcohol
Caution
It is unknown whether Cyramza 500 Injection 50 ml interacts with alcohol. Consult your doctor for more information.
Pregnancy
Unsafe
Cyramza 500 Injection 50 ml is not recommended for use in pregnancy as it may cause embryo-fetal toxicity and harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Cyramza 500 Injection 50 ml. You should not become pregnant while you are receiving Cyramza 500 Injection 50 ml for at least three months from the last dose of Cyramza 500 Injection 50 ml. Using effective birth control methods while on treatment is suggested.
Breast Feeding
Unsafe
Cyramza 500 Injection 50 ml should not be taken if you are breastfeeding as it passes into breast milk and may harm your infant. Avoid nursing your child while on treatment with this medicine and for at least two months from the last dose of medicine.
Driving
Not applicable
Cyramza 500 Injection 50 ml will be administered to hospitalized patients. Driving is not recommended.
Liver
Safe if prescribed
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Cyramza 500 Injection 50 ml. Based on population PK analysis, no dose adjustment is advised for patients with mild liver impairment. Patients with Child-Pugh B or C cirrhosis who received single-agent Cyramza 500 Injection 50 ml reported clinical deterioration.
Kidney
Safe if prescribed
Hence, if you have a pre-existing or a history of kidney disease, inform your doctor. Based on population PK analysis, no dose adjustment is advised for patients with kidney impairment.
Children
Unsafe
Cyramza 500 Injection 50 ml is not recommended for use in children as the safety and efficacy are not established.
Keep Refrigerated. Do not freeze.Prepaid payment required.
About Cyramza 500 Injection 50 ml
Cyramza 500 Injection 50 ml is an anti-cancer medicine used alone or in combination with other combination medicines for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma, hepatocellular cancer, colorectal cancer, and non-small cell lung cancer. Cancer is a disease where the cells grow abnormally and divide uncontrollably. It can also be used when the cancer has spread to other parts of the body.
Cyramza 500 Injection 50 ml contains Ramucirumab as an active ingredient, which belongs to the class of monoclonal antibodies. It works by inhibiting the abnormal growth of cancer cells and, finally, causes the initiation of programmed cell death.
Cyramza 500 Injection 50 ml may cause some side effects, such as abdominal pain, dry mouth, mouth sores, increased blood pressure, diarrhoea, fatigue, nausea, headache, nose bleeds, vomiting, tiredness, and injection site reactions. If the side effects persist or bother you, please consult your doctor. Cyramza 500 Injection 50 ml will be administered by a doctor experienced in the administration of cancer medicine. Do not self-administer.
Avoid taking it and inform your doctor if you are allergic to Cyramza 500 Injection 50 ml or its components. Inform your doctor if you have any cardiovascular conditions, heart attack, stroke, increased blood pressure, any planned surgery, lung problems, or liver/kidney disease, as it can cause adverse effects. Cyramza 500 Injection 50 ml is known to cause embryo-fetal toxicity. Hence, if you are pregnant or breastfeeding, inform your doctor beforehand.
Uses of Cyramza 500 Injection 50 ml
Medicinal Benefits
Cyramza 500 Injection 50 ml contains Trastuzumab, which is used for treating patients with different types of cancer. This medicine works by inhibiting the excess production of a human vascular endothelial growth factor receptor 2, which is responsible for the growth and spread of cancer cells. This causes inhibition of the cancer cell growth and, finally, initiation of programmed cell death.
Directions for Use
Side Effects of Cyramza 500 Injection 50 ml
Drug Warnings
Cyramza 500 Injection 50 ml should be avoided if you are allergic to it or any other components of this medicine. Before taking Cyramza 500 Injection 50 ml, inform your doctor if you have any history of cardiovascular conditions, heart attack, stroke, increased blood pressure, any planned surgery, lung problems, or liver or kidney disease, as it can cause adverse effects. Cyramza 500 Injection 50 ml may cause Cyramza 500 Injection 50 ml may cause reversible posterior leukoencephalopathy syndrome, arterial thromboembolic events, hypertension, an increased risk of hemorrhage, infusion-related reactions, gastrointestinal perforation, and clinical deterioration in patients with cirrhosis during the treatment. Hence, careful observation should be performed for any reactions in the patient. Cyramza 500 Injection 50 ml may cause embryo-fetal toxicity. Hence, if you are pregnant or planning to become pregnant, inform your doctor beforehand. Breastfeeding should be discontinued in nursing mothers during the treatment. Cyramza 500 Injection 50 ml is not recommended for use in children as the safety and efficacy are not established.
Drug-Drug Interactions
Drug-Food Interactions
Drug-Diseases Interactions
Drug-Drug Interactions Checker List
Habit Forming
Special Advise
Diet & Lifestyle Advise